期刊
EUROPEAN JOURNAL OF HUMAN GENETICS
卷 22, 期 9, 页码 1085-1092出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2013.292
关键词
hereditary diffuse gastric cancer (HDGC); nonsense suppression; suppressor-tRNA; premature termination codon (PTC)
资金
- Calouste Gulbenkian Foundation
- COMPETE/FEDER FCT [PTDC/SAU-GMG/098850/2008]
- FCT [SFRH/BD/46462/2008, PTDC/SAU-GMG/110785/2009]
- [PTDC/SAU-GMG/72168/2006]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/46462/2008, PTDC/SAU-GMG/110785/2009, PTDC/SAU-GMG/098850/2008, PTDC/SAU-GMG/72168/2006] Funding Source: FCT
Hereditary diffuse gastric cancer (HDGC) syndrome, although rare, is highly penetrant at an early age, and is severe and incurable because of ineffective screening tools and therapy. Approximately 45% of HDGC families carry germline CDH1/E-cadherin alterations, 20% of which are nonsense leading to premature protein truncation. Prophylactic gastrectomy is the only recommended approach for all asymptomatic CDH1 mutation carriers. Suppressor-tRNAs can replace premature stop codons (PTCs) with a cognate amino acid, inducing readthrough and generating full-length proteins. The use of suppressor-tRNAs in HDGC patients could therefore constitute a less invasive therapeutic option for nonsense mutation carriers, delaying the development of gastric cancer. Our analysis revealed that 23/108 (21.3%) of E-cadherin-mutant families carried nonsense mutations that could be potentially corrected by eight suppressor-tRNAs, and arginine was the most frequently affected amino acid. Using site-directed mutagenesis, we developed an arginine suppressor-tRNA vector to correct one HDGC nonsense mutation. E-cadherin- deficient cell lines were transfected with plasmids carrying simultaneously the suppressor-tRNA and wild-type or mutant CDH1 mini-genes. RT-PCR, western blot, immunofluorescence, flow cytometry and proximity ligation assay (PLA) were used to establish the model, and monitor mRNA and protein expression and function recovery from CDH1 vectors. Cells expressing a CDH1 mini-gene, carrying a nonsense mutation and the suppressor-tRNA, recovered full-length E-cadherin expression and its correct localization and incorporation into the adhesion complex. This is the first demonstration of functional recovery of a mutated causative gene in hereditary cancer by cognate amino acid replacement with suppressor-tRNAs. Of the HDGC families, 21.3% are candidates for correction with suppressor-tRNAs to potentially delay cancer onset.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据